These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. CNIs: immediate benefits but storing problems for the future? Kiuchi T Transplantation; 2008 Oct; 86(8):1026-7. PubMed ID: 18946338 [TBL] [Abstract][Full Text] [Related]
6. Is there such a thing as protocol immunosuppression in liver transplantation? McCaughan GW; Sze KC; Strasser SI Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):1-4. PubMed ID: 25164689 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppression Practices in Liver Transplantation: A Survey of North American Centers. Hussaini T; Turgeon RD; Partovi N; Erb SR; Scudamore CH; Yoshida EM Exp Clin Transplant; 2018 Oct; 16(5):550-553. PubMed ID: 28847263 [TBL] [Abstract][Full Text] [Related]
8. Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry. Cheng EY; Everly MJ Clin Transpl; 2014; ():13-26. PubMed ID: 26281123 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients. Kuypers DR Clin Pharmacol Ther; 2010 Nov; 88(5):595-6; author reply 597. PubMed ID: 20664539 [No Abstract] [Full Text] [Related]
11. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N Clin Transpl; 2011; ():223-35. PubMed ID: 22755416 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppression with budesonide for liver transplant recipients with severe infections. Bhat M; Ghali P; Wong P; Marcus V; Michel R; Cantarovich M; Metrakos P; Deschenes M Liver Transpl; 2012 Feb; 18(2):262-3. PubMed ID: 22006869 [No Abstract] [Full Text] [Related]
13. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508 [TBL] [Abstract][Full Text] [Related]
15. Alemtuzumab and liver transplantation: a review. Dhesi S; Boland B; Colquhoun S Curr Opin Organ Transplant; 2009 Jun; 14(3):245-9. PubMed ID: 19417659 [TBL] [Abstract][Full Text] [Related]
16. Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both? Feng S Curr Opin Organ Transplant; 2008 Oct; 13(5):506-12. PubMed ID: 19060534 [TBL] [Abstract][Full Text] [Related]
17. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients. Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665 [TBL] [Abstract][Full Text] [Related]